{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T12:58:53Z","timestamp":1793278733866,"version":"4.5.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007771","name":"Medical University of Silesia in Katowice","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Polycystic ovary syndrome (PCOS) is a complex endocrine disorder affecting 6\u201322% of women worldwide, with adolescent diagnosis posing significant challenges due to physiological differences between adolescents and adults. Historically, the application of the Rotterdam criteria in adolescent girls led to overdiagnosis, prompting the introduction of revised adolescent-specific criteria in 2017. These updated criteria require the presence of both irregular menstrual cycles and hyperandrogenism while excluding criterion of polycystic ovarian morphology. This study aims to assess whether a PCOS diagnosis based on adolescent-specific criteria correlates with an increased risk of metabolic disturbances in adulthood.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A retrospective analysis was conducted on medical records of 34 adolescent patients diagnosed with PCOS according to the Rotterdam criteria, who were divided into a study group (SG, n=23) meeting the updated adolescent PCOS criteria and a comparison group (CG, n=11) that did not meet these criteria. After the mean follow-up of 5.5 years, they were reassessed based on clinical and metabolic parameters. Clinical assessments included body mass index (BMI), Ferriman-Gallwey scale, and body composition analysis. Biochemical analyses involved fasting lipid profiles, glucose metabolism markers, and insulin resistance indices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Application of the updated diagnostic criteria resulted in a 33% reduction in PCOS diagnoses among adolescents. No significant differences in BMI were observed between SG and CG on the first and second visits. The triglycerides (TG) to HDL-cholesterol (HDL-C) ratio was significantly higher in the SG across both time points (p=0.029 in adolescence, p=0.049 in adulthood), correlating positively with insulin levels during adolescence (p=0.005, R=0.61). Additionally, HDL-C levels were consistently lower in the SG than in CG (p=0.025 in adolescence, p=0.033 in adulthood).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The findings of this study suggest that the revised PCOS criteria in adolescence may assist in identifying individuals at risk of long-term metabolic abnormalities. Elevated TG\/HDL-C ratios and persistent HDL-C abnormalities observed in the study group may indicate a metabolic predisposition independent of obesity. These preliminary results emphasize the potential importance of early metabolic monitoring in adolescent PCOS patients; however, they should be interpreted with caution and confirmed in larger cohorts to ensure sufficient statistical power and broader generalizability.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2025.1579217","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:23:32Z","timestamp":1748928212000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":13,"title":["Adolescent PCOS and long-term metabolic risk: insights from triglycerides to high-density lipoprotein cholesterol ratio and high-density lipoprotein cholesterol profiles"],"prefix":"10.3389","volume":"16","author":[{"given":"Maria","family":"Nowak-Cio\u0142ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia Jagoda","family":"Stachowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Krok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Sokal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u017baneta","family":"Malczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Skrzy\u0144ska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Zachurzok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.892125","article-title":"The lipid profiles in different characteristics of women with PCOS and the interaction between dyslipidemia and metabolic disorder states: a retrospective study in Chinese population","volume":"13","author":"Guo","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.ecl.2020.10.002","article-title":"Diagnosis of polycystic ovary syndrome: which criteria to use and when","volume":"50","author":"Chang","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.5603\/GP.a2017.0055","article-title":"The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS","volume":"88","author":"Altintas","year":"2017","journal-title":"Ginekol Pol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.5114\/pedm.2023.125364","article-title":"Czy zaburzenia miesi\u0105czkowania u dorastaj\u0105cych dziewcz\u0105t s\u0105 zwi\u0105zane z zaburzeniami metabolicznymi","volume":"29","author":"Fory\u015b","year":"2023","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1210\/js.2019-00078","article-title":"Polycystic ovary syndrome: pathophysiology, presentation, and treatment with emphasis on adolescent girls","volume":"3","author":"Witchel","year":"2019","journal-title":"J Endocr Soc"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1159\/000479371","article-title":"An international consortium update: pathophysiology, diagnosis, and treatment of polycystic ovarian syndrome\u00a0in adolescence","volume":"88","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2023.07.025","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"120","author":"Teede","year":"2023","journal-title":"Fertil Steril"},{"key":"B8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.metabol.2017.09.016","article-title":"Polycystic ovarian syndrome (PCOS): long-term metabolic consequences","volume":"86","author":"Anagnostis","year":"2018","journal-title":"Metabolism"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-139-10-200311180-00007","article-title":"Use of metabolic markers to identify overweight individuals who are insulin resistant","volume":"139","author":"McLaughlin","year":"2003","journal-title":"Ann Intern Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"e98","DOI":"10.1016\/j.diabres.2011.05.030","article-title":"TyG index performs better than HOMA in a Brazilian population: a hyperglycemic clamp validated study","volume":"93","author":"Vasques","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"B11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/s12916-020-01861-x","article-title":"Updated adolescent diagnostic criteria for polycystic ovary syndrome: impact on prevalence and longitudinal body mass index trajectories from birth to adulthood","volume":"18","author":"Tay","year":"2020","journal-title":"BMC Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/1477-7827-8-14","article-title":"Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China","volume":"8","author":"Huang","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.18203\/2320-1770.ijrcog20162173","article-title":"Comparative study of clinical profile of lean and obese polycystic ovary syndrome women","volume":"5","author":"Akshaya","year":"2017","journal-title":"Int J Reprod Contracept Obstet Gynecol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2004.11.070","article-title":"Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment","volume":"83","author":"DeUgarte","year":"2005","journal-title":"Fertil Steril"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.4239\/wjd.v13.i3.129","article-title":"Markers of insulin resistance in polycystic ovary syndrome women: an update","volume":"13","author":"Amisi","year":"2022","journal-title":"World J Diabetes"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2023.2172154","article-title":"Triglyceride-glucose index is associated with metabolic syndrome in women with polycystic ovary syndrome","volume":"39","author":"Yang","year":"2023","journal-title":"Gynecol Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.20945\/2359-3997000000506","article-title":"The triglyceride-glucose index as an indicator of insulin resistance and cardiometabolic risk in Brazilian adolescents","volume":"67","author":"Reckziegel","year":"2023","journal-title":"Arch Endocrinol Metab"},{"key":"B18","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/metabo13020302","article-title":"Metabolic deregulations in patients with polycystic ovary syndrome","volume":"13","author":"Jabczyk","year":"2023","journal-title":"Metabolites"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/eurjpc\/zwae066","article-title":"Risk and incidence of cardiovascular disease associated with polycystic ovary syndrome","volume":"31","author":"Wan","year":"2024","journal-title":"Eur J Prev Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11120869","article-title":"Metabolic syndrome and PCOS: pathogenesis and the role of metabolites","volume":"11","author":"Chen","year":"2021","journal-title":"Metabolites"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-153","article-title":"Metabolic profiles characterizing different phenotypes of polycystic ovary syndrome: plasma metabolomics analysis","volume":"10","author":"Zhao","year":"2012","journal-title":"BMC Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1117761","article-title":"High density lipoprotein-associated proteins in non-obese women with and without polycystic ovary syndrome","volume":"14","author":"Butler","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2007.07.004","article-title":"Pathophysiology and types of dyslipidemia in PCOS","volume":"18","author":"Diamanti-Kandarakis","year":"2007","journal-title":"Trends Endocrinol Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1579217\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T05:23:33Z","timestamp":1748928213000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1579217\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":23,"alternative-id":["10.3389\/fendo.2025.1579217"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1579217","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"1579217"}}